TAL
TERN

TIG Advisors LLC’s Terns Pharmaceuticals TERN Stock Holding History

TIG Advisors LLC’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-511,191
Closed -$26.9M – 144
2026
Q1 		$26.9M Buy
+511,191
New +$21M 1.25% 23

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

TIG Advisors LLC's TERN Position: Q2 2026 in Review

TIG Advisors LLC sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 511,191 shares — an estimated $26.9M sold.

TIG Advisors LLC first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $26.9M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • TIG Advisors LLC reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • TIG Advisors LLC sold 511,191 Terns Pharmaceuticals shares in Q2 2026, an estimated $26.9M.
  • TIG Advisors LLC first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • TIG Advisors LLC's Terns Pharmaceuticals position peaked at $26.9M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on TIG Advisors LLC's 13F filing for Q2 2026, filed 14 Aug 2026.